Fig. 6
Decision curve analysis of nomogram compared with TNM stage for 1-year OS (A), 3-year OS (B), and 5-year OS (C) of PRNRT patients. OS, overall survival; PRNET, primary renal neuroendocrine tumor.
Fig. 6 | Scientific Reports
Decision curve analysis of nomogram compared with TNM stage for 1-year OS (A), 3-year OS (B), and 5-year OS (C) of PRNRT patients. OS, overall survival; PRNET, primary renal neuroendocrine tumor.
